Cargando…
Modeling Exposure‐Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib
Models were developed to characterize the relationship between afatinib exposure and diarrhea and rash/acne adverse event (AE) trajectories, and their predictive ability was assessed. Based on pooled data from seven phase II/III clinical studies including 998 patients, mixed‐effects models for order...
Autores principales: | Niebecker, Ronald, Maas, Hugo, Staab, Alexander, Freiwald, Matthias, Karlsson, Mats O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482278/ https://www.ncbi.nlm.nih.gov/pubmed/30681293 http://dx.doi.org/10.1002/psp4.12384 |
Ejemplares similares
-
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
por: Wind, Sven, et al.
Publicado: (2016) -
dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap
por: Dosne, Anne-Gaëlle, et al.
Publicado: (2016) -
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
por: Logan, Jessica M., et al.
Publicado: (2021) -
Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019) -
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
por: Velikyan, Irina
Publicado: (2020)